| |
107. DOG-Kongress Home
DOG-Kongressinformation
DOG-Kongress Bildergalerie
Grußworte
Organisation, Termine
Ablauf des Kongresses
Preise und Forschungsförderungen
Höhepunkte
Wissenschaftliches Programm
Feierliche Eröffnung
Schwerpunkte
Wissenschaftliches Programm
- Do, 24.09.09
- Fr, 25.09.09
- Sa, 26.09.09
- So, 27.09.09
- Posterausstellung
Symposien
Kurse
Firmenveranstaltungen
Satellitenprogramm
Hinweise, Informationen
Rahmenprogramm
Sponsoren, Industrie
Presseservice
Programm downloaden / drucken [PDF, 11 MB]
Vorprogramm downloaden / drucken [PDF, 3 MB]
DOG-Homepage
|
|
Abstract
SA.17.09
Phospholipid liposomes and hyaluronic acid in the therapy of evaporative dry eye
Karl-Georg Schmidt1, R. Khaireddin2
1Augenklinik Garmisch-Partenkirchen, Augenklinik Starnberg, Starnberg, 2Klinik und Poliklinik für Augenheilkunde, Universitätsklinikum Hamburg-Eppendorf, Hamburg
Objective
Evaporative dry eye is the most common form of tears film dysfunction.
Substitution therapy with a phospholipid-liposomal eye spray (PL-S) and an artificial tear preparation based on hyaluronic acid (Hy-D) were compared.
Methods
218 patients suffering from evaporative dry eye were included in this prospective, randomized multicenter study. Two groups were treated either with PL-S or Hy-D, each for a period of 3 months.
Tests (lid-parallel conjunctival folds (LIPCOF), Non Invasive Break up time (NIBUT), Schirmer’s Test, inspection of lids and subjective assessment) were performed before as well as 4 and 12 weeks after initiation of this study.
Results
On therapy, parameters investigated improved in both groups, with greater improvements in the PL-S group, particularly regarding the degree of inflammation of the lid margins as well as the grade of LIPCOF. When compared to Hy-D, NIBUT more than doubled in the PL-S – group.
Conclusions
Both therapies improved evaporative dry eye, but patients on phospholipid-liposomal eye spray demonstrated greater clinical benefit from their therapy.
|
|